Skip to content
We’ve expanded our free plan so you can explore more of Valuesider. Check out the updated pricing page to see what’s now available for free!
User

Pershing Square Capital Management AGN-OLD trades

Bill Ackman

Bill Ackman ALLERGAN INC/UNITED STATES stake

total: 47

Trades details

Total transactions:
4
New positions:
1
Sold out:
1
Added:
1
Reduced:
1
Held since:
2014 Q1
Held for:
4 quarters
Latest activity:
2015 Q1
According to 2026 Q2 report, Bill Ackman doesn't hold any ALLERGAN INC/UNITED STATES (AGN-OLD) shares. To date, the estimated cost basis is nearly $168.29 for "buy" trades and estimated average "sell" price is $212.59. Pershing Square Capital Management first purchased AGN-OLD in 2014 Q1, initially acquiring 597,431 shares. Since the initial investment in ALLERGAN INC/UNITED STATES (AGN-OLD), Pershing Square Capital Management has made 3 more transactions.

When did Bill Ackman sell ALLERGAN INC/UNITED STATES (AGN-OLD)?

Bill Ackman sold off the entire ALLERGAN INC/UNITED STATES (AGN-OLD) position in 2015 Q1.

When did Bill Ackman buy ALLERGAN INC/UNITED STATES (AGN-OLD)?

Bill Ackman first invested in ALLERGAN INC/UNITED STATES (AGN-OLD) in 2014 Q1 at the reported quarter-end price of $124.10 per share.

What's the cost basis of Pershing Square Capital Management's AGN-OLD stake?

The estimated cost basis for ALLERGAN INC/UNITED STATES (AGN-OLD) stake is around $168.29 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$168.29
Weighted AVG sell price:
$212.59

Bill Ackman's historical trades in ALLERGAN INC/UNITED STATES

4 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2015 Q1
0.00%
$212.59
-100% (-26,635,978)
2014 Q4
35.30%
$212.59
-7.77% (-2,242,560)
2014 Q2
38.79%
$169.22
+4,733.79% (+28,281,107)
2014 Q1
0.88%
$124.10
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.